Katherine Goodman, JD, PhD

My research applies novel informatics and machine learning/AI methods, including natural language processing (NLP) and large language models (LLMs), to large electronic health record and claims data. These projects span multiple clinical domains, from infectious diseases to oncology to maternal-fetal medicine, with a particular interest in improving the screening and diagnosis of antimicrobial resistance gut carriage and early-onset colorectal cancer.

Prior to my doctoral studies, I practiced FDA law in Washington, D.C., and the intersection of law and public health remains an important research interest. With collaborators across the School of Medicine and the School of Law, we have ongoing work focused on the legal regulation and oversight of clinical algorithms and emerging AI technologies.